Cytokine and Complement Response in the Glaucomatous βB1-CTGF Mouse Model

Glaucoma is a complex neurodegenerative disease leading to a loss of retinal ganglion cells (RGCs) and optic nerve axons. An activation of the complement system seems to contribute to cell loss in this disease. Hence, we investigated a possible initiation of the complement system and the cytokine re...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in cellular neuroscience Vol. 15; p. 718087
Main Authors: Reinehr, Sabrina, Doerner, Johanna D., Mueller-Buehl, Ana M., Koch, Dennis, Fuchshofer, Rudolf, Dick, H. Burkhard, Joachim, Stephanie C.
Format: Journal Article
Language:English
Published: Lausanne Frontiers Research Foundation 18-11-2021
Frontiers Media S.A
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Glaucoma is a complex neurodegenerative disease leading to a loss of retinal ganglion cells (RGCs) and optic nerve axons. An activation of the complement system seems to contribute to cell loss in this disease. Hence, we investigated a possible initiation of the complement system and the cytokine response in the βB1-CTGF glaucoma model. In these mice, intraocular pressure is elevated, which is the main glaucoma risk factor in patients, and RGC loss occurs at 15 weeks of age. Therefore, quantitative real-time PCR and immunohistological experiments were performed in 5-, 10-, and 15-week-old βB1-CTGF animals and their corresponding wildtypes (WT) to analyze the expression of several complement system factors. We could show that mRNA levels of the terminal complement pathway components C3 and C5 ( Hc ) were upregulated at 10 weeks. In accordance, more C3 + and membrane attack complex + cells were observed in transgenic retinae. Further, the C5a receptor anaphylatoxin receptor ( C5ar ) and the complement component C5a receptor 1 ( C5ar1 ; CD88) mRNA levels were upregulated in 10- and 15-week-old βB1-CTGF mice. Interestingly, all three activation routes of the complement system were elevated in βB1-CTGF mice at some age. Especially C1q, as a marker of the classical pathway, was significantly increased at all investigated ages. Furthermore, mRNA expression levels of interferon-γ ( Infg ) were upregulated at 5 weeks, while Cxcl1 and Cxcl2 mRNA levels were upregulated at 10 and 15 weeks. The mRNA levels of the chemokines Cxcl10 were increased at all ages in βB1-CTGF mice. These results lead to the assumption that in these transgenic mice, a complement activation mainly through the classical pathway as well as a cytokine response plays a major role in cell death.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Cellular Neuropathology, a section of the journal Frontiers in Cellular Neuroscience
Edited by: Rebecca M. Sappington, Wake Forest School of Medicine, United States
Reviewed by: Tatjana C. Jakobs, Massachusetts Eye & Ear Infirmary and Harvard Medical School, United States; Peter Heiduschka, University of Münster Medical School, Germany
ISSN:1662-5102
1662-5102
DOI:10.3389/fncel.2021.718087